Yposkesi and Axovant sign strategic gene therapy development and manufacturing partnership.
Partnership secures access to reserved cGMP capacity and resources at Yposkesi for manufacturing to support the global development and commercialization of Axovant’s gene therapy programsAxovant Yposkesi Manufacturing Partnership Announcement_…
Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology.
Servier selected Yposkesi to develop and GMP manufacture lentiviral vectors to support allogenic CAR-T cell technology development.
Come and visit Yposkesi at booth 4114 during #BIO2019 in Philadelphia, PA, next week.
BIO International Convention in Philadelphia, June 3-6, celebrates the globally important innovations in biotech that start with you. Unparalleled partnering, education, and networking. Register at convention.bio.org.
Yposkesi is proud to be a sponsor of ‘Thematic Day on Viral Vectors’ on May 17, 2019 in Paris.
The event is organized by ICM (Institut Cerveau et Moelle Epinière) and La Pitié Salpêtrière.